Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35243

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Birmingham Alabama 35294-3410

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Arizona

UPDATED

Phoenix Arizona 85015

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Scottsdale Arizona 85251

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Tucson Arizona 85723

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Arkansas

UPDATED

Little Rock Arkansas 72204-1858

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

California

UPDATED

Culver City California 90230

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Fremont California 94536

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Huntington Beach California 92648

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Long Beach California 90806

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

View More ▼

UPDATED

San Diego California 92161

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Stockton California 95204

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Torrance California 90502

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Lakewood Colorado 80228

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Connecticut

UPDATED

Norwalk Connecticut 06851

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Delaware

UPDATED

Wilmington Delaware 19803

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Florida

UPDATED

Altamonte Springs Florida 32714

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Bradenton Florida 34209

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Clearwater Florida 33756

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Clearwater Florida 33756

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Daytona Beach Florida 32114

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

View More ▼

UPDATED

Fort Lauderdale Florida 33316

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jacksonville Beach Florida 32250

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jupiter Florida 33458

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Ocala Florida 34471

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Orlando Florida 32825

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Palm Beach Gardens Florida 33410

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

St. Petersburg Florida 33701

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Tampa Florida 33613

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Wellington Florida 33449

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Georgia

UPDATED

Athens Georgia 30606

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Atlanta Georgia 30342

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Augusta Georgia 30912

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Covington Georgia 30014

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Idaho

UPDATED

Boise Idaho 83712

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Illinois

UPDATED

Fairview Heights Illinois 62208

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jerseyville Illinois 62052

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Normal Illinois 61761

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Indiana

UPDATED

Elkhart Indiana 46514

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Indianapolis Indiana 46202

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Richmond Indiana 47374

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Iowa

UPDATED

Davenport Iowa 52803

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Iowa City Iowa 52242

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Waterloo Iowa 50702

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Kansas

UPDATED

Kansas City Kansas 66160

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Wichita Kansas 67213

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Kentucky

NEW

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40353

Assessment of the WATCHMANTM Device in Patients Unsuitable for Oral Anticoagulation ASAP-TOO

View More ▼

UPDATED

Crestview Hills Kentucky 41017

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes